Business Context and Reporting Period
Company: Oddity Tech Ltd (Oddity)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Oddity is a consumer tech platform operating in the global beauty and wellness market. It utilizes proprietary AI, machine learning, and computer vision to drive its direct-to-consumer brands, primarily IL MAKIAGE and SpoiledChild. The company operates an asset-light model with significant investments in R&D through its biotechnology center, ODDITY LABS.
Key Financial Metrics (Year Ended Dec 31, 2024)
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Revenue | $647.0 million | $508.7 million | $324.5 million |
| Gross Profit | $468.3 million | $358.2 million | $218.1 million |
| Gross Margin | 72.4% | 70.4% | 67.2% |
| Operating Income | $115.6 million | $74.3 million | $27.7 million |
| Net Income | $101.5 million | $58.5 million | $21.7 million |
| Net Income Margin | 15.7% | 11.5% | 6.7% |
| Adjusted EBITDA | $150.4 million | $107.3 million | $39.5 million |
| Adjusted EBITDA Margin | 23.3% | 21.1% | 12.2% |
| Operating Cash Flow | $137.8 million | $87.5 million | $39.0 million |
| Cash & Equivalents (Dec 31, 2024) | $50.3 million | $36.5 million | N/A |
| Total Liquid Assets (Cash, Deposits, Securities) | $169.1 million | $168.4 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 27.2% year-over-year (YoY) to $647.0 million, driven primarily by increased order volume. The return rate improved, decreasing to 10.9% in 2024 from 12.0% in 2023.
- Margin Expansion: Gross margin expanded by 200 basis points to 72.4%, attributed to supply chain efficiencies and cost improvement efforts.
- Expense Management: Selling, General, and Administrative (SG&A) expenses increased 24.2% to $352.7 million, largely due to a $38.7 million increase in advertising costs to support sales growth and investments in ODDITY LABS.
- Share Repurchases: The company repurchased and retired approximately 3.6 million Class A ordinary shares in 2024 for a total of $147.3 million, including a $100 million repurchase from major shareholder L Catterton in November 2024.
- Geographic Mix: International revenue (outside the U.S.) represented approximately 15% of total net revenue in 2024, down from 19% in 2023.
Guidance, Outlook, and Risks
Management Commentary & Outlook: Oddity maintains a long-term financial algorithm targeting 20% annual revenue growth and a 20% Adjusted EBITDA margin. The company exceeded these targets in 2024. Management expects to sustain high growth and attractive margins through investments in user base expansion, brand portfolio growth (including upcoming Brand 3 and Brand 4), and global footprint expansion.
Key Risks & Contingencies:
- Geopolitical Instability: As an Israeli-incorporated company with significant operations in Israel, Oddity faces risks from ongoing regional conflicts (Hamas, Hezbollah, Houthi attacks). While no material impact on day-to-day operations was reported as of Dec 31, 2024, escalation could disrupt business, supply chains, and employee availability due to military reserve call-ups.
- Regulatory Environment: The company faces evolving regulations regarding AI (e.g., EU AI Act), data privacy (GDPR, CCPA), and cosmetic product safety (FDA, EU Cosmetics Regulation). Non-compliance could lead to fines, product recalls, or operational restrictions.
- Supply Chain: Reliance on third-party manufacturers and single-source suppliers for certain components creates vulnerability to disruptions, raw material shortages, and shipping delays (e.g., Red Sea disruptions).
- Legal Proceedings: A putative class action lawsuit (Hoare v. Oddity Tech Ltd.) was filed in February 2025 alleging securities law violations related to the IPO. The company intends to vigorously defend the action.
Investor Verification Checklist
- Geopolitical Exposure: Verify the current status of military reserve call-ups for Israeli employees and any operational disruptions in Tel Aviv or supply chain partners in the region.
- Shareholder Concentration: Confirm the voting power concentration held by CEO Oran Holtzman (approx. 76.2% of voting power via Class B shares) and its implications for corporate governance and potential change of control.
- Regulatory Compliance: Monitor developments in the EU AI Act and FDA regulations regarding cosmetic claims and ingredient safety, as these could impact product launches and marketing strategies.
- Legal Status: Track the progress of the Hoare v. Oddity Tech Ltd. securities class action lawsuit filed in early 2025.
- Debt Covenants: Review the terms of the new $200 million credit facility entered into in January 2025, specifically the financial covenants regarding shareholder equity ratio (min 20%) and net debt-to-EBITDA (max 3x).